This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum

Event begins in:

  • 00
  • 00
  • 00
  • 00
Marina Bay Sands Convention Center
April 24—25, 2024 | SingaporeApril 29—30, 2024 | Virtual

Lily Zhang
Founding and Managing partner at TTM Capital


LILY ZHANG is the founding and managing partner of TTM Capital, focusing on investments in therapeutics, medical devices, diagnose reagents, and biotech.

LILY previously served as the partner of CDH Investment, bringing nearly 15 years of experience in cross-border mergers and acquisitions, technology transfer, patent licensing, and extensive domestic and international investment experience in the life sciences field. LILY has successfully led investments in companies such as Harbour Biomed, Hitgen Inc., I-MAB Biopharma, Fuzhou Maixin Biotech, Elpiscience Biopharma, Xinthera, NeuShen Therapeutics, holding director positions in multiple companies.

Prior to joining in CDH Investment, LILY held various management positions in multiple global multinational medical companies. She was the Business Development Manager for Johnson & Johnson in China and Asia Pacific region, overseeing mergers and acquisitions and product introductions in 13 Asian countries. As the Director of Business Development and Market Information at GlaxoSmithKline China, responsible for technology transfer, product introduction, and development strategy.

LILY holds an MBA of Wharton School of the University of Pennsylvania and a PhD from Tongji University. She is the Secretary-general of SORSA Biomedical Branch, a member of The BayHelix Group, PhIRDA, SAPA, NDF Club, and the Wharton School Healthcare Club.

Agenda Sessions

  • Cross border investment: from local discovery to global innovation


At this event